No one ever said commercializing a new product would be easy, but for healthcare companies, it seems to be especially tough – in large part due to the many players involved, their convoluted and misaligned incentives, and some truly byzantine power dynamics governing the system.

Paul Sequeira

Paul Sequeira came to Newry in 2015 from Thermalin Diabetes, a Cleveland biotech startup, where he was involved in new product development and supported efforts to secure venture capital funding. As a Newry consultant, Paul has led engagements in markets ranging from automotive to semiconductors, and many of his recent projects have focused on the life sciences and medical spaces. He has developed the commercialization strategy for a consumer healthcare product, initiated customer engagement for a novel bio-agricultural technology, and identified and evaluated dozens of opportunities for engineered materials, including technical analyses and go-to-market strategies.

Find out how we can help